Weiqi Zeng
- Molecular Biology top 10%
- Immunology top 10%
- Infectious Diseases top 5%
- Oncology
- Biomedical Engineering
- Topics
- Signaling Pathways in Disease (13 papers)Parkinson's Disease Mechanisms and Treatments (12 papers)Neuroscience and Neuropharmacology Research (7 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Weiqi Zeng
71 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 1.0k
- Immunology 256
- Infectious Diseases 249
- Oncology 214
- Biomedical Engineering 195
Countries citing papers authored by Weiqi Zeng
This map shows the geographic impact of Weiqi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Zeng more than expected).
Fields of papers citing papers by Weiqi Zeng
This network shows the impact of papers produced by Weiqi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Zeng. The network helps show where Weiqi Zeng may publish in the future.
Co-authorship network of co-authors of Weiqi Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Weiqi Zeng. A scholar is included among the top collaborators of Weiqi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqi Zeng. Weiqi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 11 | |
| 7 | 16 | |
| 8 | 1 | |
| 9 | 8 | |
| 10 | 34 | |
| 11 | 20 | |
| 12 | 18 | |
| 13 | 11 | |
| 14 | 12 | |
| 15 | 10 | |
| 16 | 19 | |
| 17 | 11 | |
| 18 | 3 | |
| 19 | 46 | |
| 20 | 27 |
About Weiqi Zeng
Weiqi Zeng is a scholar working on Neurology, Molecular Biology and Applied Microbiology and Biotechnology, having authored 79 papers that have together received 1.9k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (13 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Infectious Diseases (249 citations) and Immunology (256 citations). Weiqi Zeng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Juan Su, Xiang Chen, Cong Peng, Jianglin Zhang, Teng Xu, Jingwen Ai, Xuebing Cao, Xiaorui Wang, Yehong Kuang and Xuekun Jia. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.